Home Page: Thrombosis Research

Time 2020-10-20 09:04:12

Web Name: Home Page: Thrombosis Research

WebSite: http://www.thrombosisresearch.com

ID:88092

Keywords:

Page,Home,Research,

Description:

Issue Highlights Venous thromboembolic events in inflammatory bowel diseases: A review of current evidence and guidance on risk in the post-hospitalization settingSanjay K. Murthy, Arleigh B. Robertson McCurdy, Marc Carrier, Jeffrey D. McCurdyDOI: https://doi.org/10.1016/j.thromres.2020.06.005Vol. 194, p26 32Published online: June 3, 2020Full-Text HTMLPDFIs COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature reviewAlexander Fletcher-Sandersjöö, Bo-Michael BellanderDOI: https://doi.org/10.1016/j.thromres.2020.06.027Vol. 194, p36 41Published online: June 17, 2020Open AccessFull-Text HTMLPDFThe hypercoagulable state in COVID-19: Incidence, pathophysiology, and managementMouhamed Yazan Abou-Ismail, Akiva Diamond, Sargam Kapoor, Yasmin Arafah, Lalitha NayakDOI: https://doi.org/10.1016/j.thromres.2020.06.029Vol. 194, p101 115Published online: June 19, 2020Full-Text HTMLPDF Tolerance of anticoagulation in hereditary hemorrhagic telangiectasiaNicolas Tentoni, Martin I. Lapidus, Veronica A. Peuchot, Fernando J. Vazquez, Marcelo M. SerraDOI: https://doi.org/10.1016/j.thromres.2020.10.019Publication stage: In Press Journal Pre-ProofPreviewPDFxDespite being a hemorrhagic condition, patients with hereditary hemorrhagic telangiectasia (HHT) are at increased thromboembolic risk. We designed an observational retrospective cohort study of HHT patients who required anticoagulation therapy, described their indications and adverse events. From January 2006 until August 2019 28 out of 347 adult HHT patients received anticoagulant drugs for a median of 0.5 years (IQR 0.2–4.1). Median age was 64 years (IQR 51–70), all of the patients had epistaxis and at least one arteriovenous malformation.UK real-world experience of prescribing rivaroxaban for acute venous thromboembolism in obesity: Results from the FIRST registryV. Speed, J.P. Patel, L.N. Roberts, R.K. Patel, R. Arya, for the FIRST Registry InvestigatorsDOI: https://doi.org/10.1016/j.thromres.2020.10.021Publication stage: In Press Journal Pre-ProofPDFMore precise dosing of acenocoumarol for better control in patients aged above 80 years, a randomised controlled pilot studyM. Piersma-Wichers, J.H.A. van Miert, N.J.G.M. Veeger, H.A.M. Kooistra, K. MeijerDOI: https://doi.org/10.1016/j.thromres.2020.10.018Publication stage: In Press Journal Pre-ProofPreviewPDFxMany elderly patients are confined to treatment with vitamin K antagonists (VKA) instead of direct oral anticoagulants (DOACs). However, quality of VKA treatment declines with age. This might be caused by the lower dose requirements with increasing age, which result in relatively large day-by-day VKA dose differences. Therefore, more precise dosing with smaller dose increments might improve quality of VKA treatment in the elderly.Thrombotic Antiphospholipid Syndrome: a practical guide to diagnosis and managementZara Sayar, Rachel Moll, David Isenberg, Hannah CohenDOI: https://doi.org/10.1016/j.thromres.2020.10.010Publication stage: In Press Journal Pre-ProofPreviewPDFxThrombotic antiphospholipid syndrome (APS) is characterised by venous, arterial or microvascular thrombosis in the context of persistently positive antiphospholipid antibodies (aPL). The diagnosis and management of thrombotic APS continues to prove challenging for clinicians. We provide a practical guide to the diagnosis of APS including who to test for aPL and which tests to do. We also consider clinical practice points on the management of venous, arterial and small vessel thrombosis, in the context of first and recurrent thrombotic events.Impact of atrial fibrillation/flutter on the in-hospital mortality of surgical patients – results from the German nationwide cohortKarsten Keller, Lukas Hobohm, Martin EngelhardtDOI: https://doi.org/10.1016/j.thromres.2020.10.015Publication stage: In Press Journal Pre-ProofPreviewPDFxTo investigate the impact of atrial fibrillation/flutter (AF) on adverse in-hospital outcomes in hospitalized surgical patients. Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)DOI: https://doi.org/10.1016/j.thromres.2020.09.026Thrombosis Research, Vol. 196Incidence of thrombotic complications in critically ill ICU patients with COVID-19DOI: https://doi.org/10.1016/j.thromres.2020.04.013Thrombosis Research, Vol. 191Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, ItalyDOI: https://doi.org/10.1016/j.thromres.2020.04.024Thrombosis Research, Vol. 191Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studiesDOI: https://doi.org/10.1016/j.thromres.2020.09.027Thrombosis Research, Vol. 196The hazard of fondaparinux in non-critically ill patients with COVID-19: Retrospective controlled study versus enoxaparinDOI: https://doi.org/10.1016/j.thromres.2020.09.024Thrombosis Research, Vol. 196 About Thrombosis Research Thrombosis Research was established in 1972 and is an international journal with a goal of rapid dissemination of new information on thrombosis, hemostasis, and vascular biology to advance science and clinical care. The journal publishes peer-reviewed original research, along with reviews, editorials, and opinions and critics. Both basic and clinical studies are published. Publication of research which will lead to novel approaches in diagnosis, therapy, prognosis and prevention of thrombotic and hemorrhagic diseases is given high priority. Rapid communication and high visibility is facilitated by on-line submission, processing, and dissemination. Journal Access Articles are available from 1972 to the present. Access to abstracts is complimentary. Access to full text is limited to personal subscribers.Activate Online Access Access this journal on ScienceDirect Visit ScienceDirect to see if you have access via your institution. Clinical presentation and outcomes in elderly patients with symptomatic isolated subsegmental pulmonary embolismNina Stoller, Andreas Limacher, Marie Méan, Christine Baumgartner, Tobias Tritschler, Marc Righini, Jürg-Hans Beer, Nicolas Rodondi, Drahomir AujeskyDOI: https://doi.org/10.1016/j.thromres.2019.10.008Vol. 184Published online: October 22, 2019 Attention Authors Thrombosis Research requires that all manuscripts be submitted electronically.Submit ManuscriptYou may also use this system to track your manuscript through the review process.Track ManuscriptYou may also view author guidelines or track your article, post acceptance, by visiting:Author Gateway Journal Insights These journal metrics provide authors with extra insight into the journals and help them in their journal selection process when submitting an article for publication.

TAGS:Page Home Research 

<<< Thank you for your visit >>>

Hot Websites